Prenatal Choline Supplement in a Maternal Obesity Model Modulates Offspring Hepatic Lipidomes
Nutrients · 2023
DOI: 10.3390/nu15040965 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Hunter W Korsmo und 7 weiteren Autor:innen. Beteiligte Einrichtung: PhD Program in Biochemistry, Graduate Center of the City University of New York, New York, NY 10016, USA. Hauptthemen laut MEDLINE: Pregnancy in Obesity, Non-alcoholic Fatty Liver Disease, Prenatal Exposure Delayed Effects. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCATS NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Maternal obesity during pregnancy adversely impacts offspring health, predisposing them to chronic metabolic diseases characterized by insulin resistance, dysregulated macronutrient metabolism, and lipid overload, such as metabolic-associated fatty liver disease (MAFLD). Choline is a semi-essential nutrient involved in lipid and one-carbon metabolism that is compromised during MAFLD progression. Here, we investigated under high-fat (HF) obesogenic feeding how maternal choline supplementation (CS) influenced the hepatic lipidome of mouse offspring. Our results demonstrate that maternal HF+CS increased relative abundance of a subclass of phospholipids called plasmalogens in the offspring liver at both embryonic day 17.5 and after 6 weeks of postnatal HF feeding. Consistent with the role of plasmalogens as sacrificial antioxidants, HF+CS embryos were presumably protected with lower oxidative stress. After postnatal HF feeding, the maternal HF+CS male offspring also had higher relative abundance of both sphingomyelin d42:2 and its side chain, nervonic acid (FA 24:1). Nervonic acid is exclusively metabolized in the peroxisome and is tied to plasmalogen synthesis. Altogether, this study demonstrates that under the influence of obesogenic diet, maternal CS modulates the fetal and postnatal hepatic lipidome of male offspring, favoring plasmalogen synthesis, an antioxidative response that may protect the mouse liver from damages due to HF feeding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PhD Program in Biochemistry, Graduate Center of the City University of New York, New York, NY 10016, USA.
- Department of Health and Nutrition Sciences, Brooklyn College of the City University of New York, Brooklyn, NY 11210, USA.
- Department of Biology, Brooklyn College of the City University of New York, New York, NY 11210, USA.
- Yale School of Public Health, Yale University, New Haven, CT 06510, USA.
ORCID-Profile: Hunter W Korsmo, Isma'il Kadam, Anjana Saxena, Caroline H Johnson, Xinyin Jiang
Förderung
- NIGMS NIH HHS
- NCATS NIH HHS
- NIDDK NIH HHS
- The National Institute of General Medical Sciences (NIGMS)
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Zitieren
APA
Korsmo, H. W., Kadam, I., Reaz, A., Bretter, R., Saxena, A., Johnson, C. H., Caviglia, J. M., & Jiang, X. (2023). Prenatal Choline Supplement in a Maternal Obesity Model Modulates Offspring Hepatic Lipidomes. Nutrients. https://doi.org/10.3390/nu15040965
Vancouver
Korsmo HW, Kadam I, Reaz A, Bretter R, Saxena A, Johnson CH, et al. Prenatal Choline Supplement in a Maternal Obesity Model Modulates Offspring Hepatic Lipidomes. Nutrients. 2023. doi:10.3390/nu15040965
BibTeX
@article{Korsmo2023,
author = {Korsmo, Hunter W and Kadam, Isma'il and Reaz, Aziza and Bretter, Rachel and Saxena, Anjana and Johnson, Caroline H and Caviglia, Jorge Matias and Jiang, Xinyin},
title = {Prenatal Choline Supplement in a Maternal Obesity Model Modulates Offspring Hepatic Lipidomes},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15040965}
}
EUVIMED